For instance, a study conducted by Anholm et al. showed that in patients with stable CAD and newly diagnosed T2D receiving standard statin therapy, liraglutide in combination with metformin improved lipid profile and reduced C-reactive protein (CRP) blood levels [147]. The gene discussed is CRP; the disease is coronary artery disorder.